Aktie A2AQ87 KONTAFARMA CHINA HOLDINGS LIMITED
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen Kontafarma China Holdings Limited

Aktien

A2AQ87

KYG8918D1088

1312

Markt geschlossen - Hong Kong S.E.
Andere Börsenplätze
 10:08:17 07.05.2024 		% 5 Tage % 1. Jan.
0.032 HKD 0.00% Intraday Chart für Kontafarma China Holdings Limited 0.00% -11.11%
02.05. Active Gains reicht Liquidationsantrag gegen Tochtergesellschaft von Kontafarma China ein MT
19.04. Kontafarma China Holdings Limited kündigt Änderungen im Management an, die am 19. April 2024 wirksam werden CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
Active Gains Files Winding-Up Petition Against Kontafarma China's Subsidiary
Kontafarma China Holdings Limited Announces Management Changes, Effect from 19 April 2024
Kontafarma China Holdings Limited Reports Earnings Results for the Full Year Ended December 31, 2023
Kontafarma China Warns of Up to HK$74 Million Loss in 2023
Kontafarma China Holdings Limited Provides Consolidated Earnings Guidance for the Year Ended 31 December 2023
Kontafarma China Holdings Limited Reports Earnings Results for the Half Year Ended June 30, 2023
Kontafarma China to Swing to H1 Profit
Kontafarma China Holdings Limited Provides Earnings Guidance for the Six Months Ended 30 June 2023
Kontafarma China's Fitness Unit Renews Rent in Singapore Mall; Shares Up 3%
Kontafarma China Unit to Sell 66% Equity Interest of Shaanxi Unisplendour for 168.2 Million Yuan; Shares Slip 7%
Kontafarma China Holdings Limited Reports Earnings Results for the Full Year Ended December 31, 2022
Kontafarma China Warns of Bigger Loss in 2022
Kontafarma China Holdings Limited Provides Group Earnings Guidance for the Year Ended December 31, 2022
Tongfang Kontafarma Holdings Limited Reports Earnings Results for the Half Year Ended June 30, 2022
Tongfang Kontafarma Holdings Limited Provides Consolidated Earnings Guidance for the Six Months Ended 30 June 2022
Tongfang Kontafarma Shareholders to Vote June 20 on $24 Million Sale of Majority Stake in SPF Biotechnology
Tongfang Kontafarma Holdings Limited Announces Management Changes
Tongfang Kontafarma Holdings Limited Reports Earnings Results for the Full Year Ended December 31, 2021
Tongfang Kontafarma Unit Seeks Damages from Alleged Breach of Fitness Brand Investment Deal
Tongfang Kontafarma Holdings Limited Announces Change of Principal Place of Business
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A2AQ87 Aktie
  4. Nachrichten Kontafarma China Holdings Limited
  5. Andere Sprachen